T-cell prolymphocytic leukemia diagnostic study of choice: Difference between revisions
No edit summary |
|||
Line 7: | Line 7: | ||
==Diagnostic Study of Choice== | ==Diagnostic Study of Choice== | ||
There are no established [[Diagnostic criteria|criteria for the diagnosis]] of T-cell prolymphocytic leukemia. [[Patient|Patients]] with T-cell prolymphocytic leukemia are diagnosed by clinical presentation, | There are no established [[Diagnostic criteria|criteria for the diagnosis]] of T-cell prolymphocytic leukemia. [[Patient|Patients]] with T-cell prolymphocytic leukemia are diagnosed by clinical presentation, evaluation of the [[peripheral blood]] and [[bone marrow]]. [[Flow cytometry]] and [[immunohistochemistry]] should be performed to diagnose a [[T cell]] [[Immunophenotyping|immunophenotype]]. | ||
==References== | ==References== |
Revision as of 15:00, 4 April 2019
T-cell prolymphocytic leukemia Microchapters |
Differentiating T-cell prolymphocytic leukemia historical perspective from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
T-cell prolymphocytic leukemia diagnostic study of choice On the Web |
American Roentgen Ray Society Images of T-cell prolymphocytic leukemia diagnostic study of choice |
FDA on T-cell prolymphocytic leukemia diagnostic study of choice |
CDC on T-cell prolymphocytic leukemia diagnostic study of choice |
T-cell prolymphocytic leukemia diagnostic study of choice in the news |
Blogs on T-cell prolymphocytic leukemia diagnostic study of choice |
Risk calculators and risk factors for T-cell prolymphocytic leukemia diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2], Maria Fernanda Villarreal, M.D. [3]
T-cell prolymphocytic leukemia Microchapters |
Differentiating T-cell Prolymphocytic Leukemia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
T-cell prolymphocytic leukemia diagnostic study of choice On the Web |
American Roentgen Ray Society Images of T-cell prolymphocytic leukemia diagnostic study of choice |
FDA on T-cell prolymphocytic leukemia diagnostic study of choice |
CDC on T-cell prolymphocytic leukemia diagnostic study of choice |
T-cell prolymphocytic leukemia diagnostic study of choice in the news |
Blogs on T-cell prolymphocytic leukemia diagnostic study of choice |
Directions to Hospitals Treating T-cell prolymphocytic leukemia |
Risk calculators and risk factors for T-cell prolymphocytic leukemia diagnostic study of choice |
Overview
There is no established diagnostic criteria.
Diagnostic Study of Choice
There are no established criteria for the diagnosis of T-cell prolymphocytic leukemia. Patients with T-cell prolymphocytic leukemia are diagnosed by clinical presentation, evaluation of the peripheral blood and bone marrow. Flow cytometry and immunohistochemistry should be performed to diagnose a T cell immunophenotype.